Has Christopher Palines, PA received payments from drug or device companies?

Yes. Drug and device makers reported $41,639 in general payments to Christopher Palines, PA across 952 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Palines, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Palines, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Palines, PA

Physician Assistant · Yonkers, NYNPI 1851542583

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Incyte Corporation accounts for 60.7% of it on its own, with 27 other manufacturers making up the rest. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,639in general payments, 2019–2025

Across 952 payments — averaging $43.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$25K
AbbVie$2K
Dermavant Sciences, Inc.$2K
Johnson & Johnson$1K
LEO Pharma Inc.$1K
E.r. Squibb & Sons, L.L.C.$1K
plus $8K from 22 others

What the payments were for

Consulting fees$9902%
Speaking & faculty fees$19,77547%
Travel & lodging$1,0773%
Food & beverage$19,14446%
Education$6532%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	204	$25,276
AbbVie	124	$2,428
Dermavant Sciences, Inc.	45	$2,327
Johnson & Johnson	48	$1,314
LEO Pharma Inc.	102	$1,294
E.r. Squibb & Sons, L.L.C.	68	$1,243
Pfizer	53	$1,188
Regeneron Healthcare Solutions, Inc.	37	$1,093
Sanofi	31	$870
Amgen	45	$854
Novartis	20	$629
Sun Pharmaceutical Industries Inc.	32	$589
Arcutis Biotherapeutics, Inc.	34	$505
Lilly USA, LLC	21	$462
UCB, Inc.	22	$402
VYNE Pharmaceuticals Inc.	18	$238
Journey Medical Corporation	8	$128
Biofrontera Inc.	6	$121
Galderma Laboratories, L.p.	7	$118
Verrica Pharmaceuticals Inc.	5	$114
Botanix SB Inc	4	$106
Ortho Dermatologics, A Division Of Bausch Health US, LLC	4	$82
EPI Health, LLC	4	$71
Dermira, Inc.	4	$63
Almirall LLC	2	$45
Strata Skin Sciences, Inc.	2	$30
Organon	1	$25
LNHC, Inc	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OPZELURA$22,227
VTAMA$1,668
Sotyktu$259
DUPIXENT$121
COSENTYX$100

How this compares

$41,639 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York →

Medicare billing

Part B allowed, 2024

$36,399

Medicare patients

143

Services billed

2,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tacrolimus	60	$11,020
Clobetasol Propionate	35	$1,828
Tretinoin	12	$1,153
Clindamycin Phosphate	13	$853
Betamethasone Dipropionate	15	$741
Doxycycline Hyclate	14	$698
Ketoconazole	34	$655
Triamcinolone Acetonide	46	$456
Mupirocin	45	$282
Nystatin	17	$225

Paid to pharmacies, not to this prescriber.

Other physician assistant in Yonkers

Henry YuBronx$1M
Michael AsbachAmherst$962K
Janelle BunceJamestown$565K
Kristyl Cuenca-SiskoNew York$478K
Melissa WhiteGarden City$320K
Lawrence HermanHolbrook$315K
Kaitlyn NelsonBrooklyn$289K
Sari KatzGarden City$271K
Julius NwosuBronx$256K
Cameron KiserNew York$225K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →